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Information on the preparation and properties of starch/gelatin blend microparticles with and without crosslinking for
drug delivery is presented. The blend microparticles were prepared by the water-in-oil emulsion solvent diffusion method.
Glutaraldehyde and methylene blue were used as the crosslinker and the water-soluble drug model, respectively. The blend
microparticles were characterized by scanning electron microscopy (SEM), Fourier transform infrared (FTIR) spectroscopy, and
UV-Visspectroscopy.ThefunctionalgroupsofthestarchandgelatinblendmatricesweredeterminedfromtheFTIRspectra.Blend
m i c r o p a r t i c l e sw i t han e a r l ys p h e r i c a ls h a p ea n di n t e r n a lp o r o u ss t r u c t u r ew e r eo b s e r v e df r o mS E Mi m a g e s .Th ea v e r a g ep a r t i c l e
sizeofthegelatinmicroparticlesdependedonthecrosslinkerratiobutnotonthestarch/gelatinblendratio.Theinvitrodrugrelease
contentsignificantlydecreasedasthecrosslinkerratioincreasedandthestarchblendratiodecreased.Theresultsdemonstratedthat
the starch/gelatin blend microparticles should be a useful controlled release delivery carrier for water-soluble drugs.
1. Introduction
The development of biocompatible polymeric microparticles
for controlled release drug delivery applications has been a
subjectofgreatinterestforthepastfewdecades[1–4].Gelatin
derived from collagen is a biodegradable and biocompatible
natural polymer that has recently been extensively inves-
tigated as a biomaterial for use in biomedical applications
such as tissue engineering [5] and drug delivery [6, 7]. The
water-in-oil (W/O) emulsion-coacervation method has been
widely used to prepare gelatin microparticles [6–8]. In this
method, the W/O emulsion droplets of gelatin solution were
crosslinkedbycrosslinkingagentssuchasglutaraldehydeand
genipin solutions. Starch is a nontoxic and biodegradable
polysaccharide that has been widely investigated for biomed-
ical [9]a n dp h a r m a c e u t i c a l[ 10, 11] applications. The swelling
and dissolution of both gelatin and starch microparticles
have been controlled by chemical crosslinking [6–8, 10, 11].
However, the formation of crosslinked starch/gelatin blend
microparticles as a drug delivery system has not yet been
reported.
Our previous work has shown that the W/O emul-
sion solvent diffusion method was a potential method for
preparing hydrophilic polymeric microparticles such as chi-
tosan [4], starch [4, 11], and silk fibroin [12, 13]. In the
present work, starch/gelatin blend microparticles containing
a water-soluble model drug were prepared by the water-in-
oil emulsion method. The influences of the glutaraldehyde-
crosslinking and starch/gelatin blend ratio on microparticle
characteristics and drug release profile were determined.
2. Materials and Methods
2.1. Materials. Gelatin powder was purchased from
LabChem (Pennsylvania, USA). Water-soluble starch was
provided by BDH Chemicals (Poole, UK). Glutaraldehyde
solution (50% in water, 5.6M) was purchased from Fluka
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( S t e i n h e i m ,G e r m a n y ) .M e t h y l e n eb l u e( 9 8 % )w a su s e da s
a water-soluble model drug and purchased from Ajax
Finechem (New South Wales, Australia). All chemicals were
used without further purification.
2.2. Preparation of Drug-Loaded Blend Microparticles. The
drug-loaded gelatin microparticles were prepared by the
W/O emulsion solvent diffusion method. 2.0mL of a 1%
(w/v) gelatin aqueous solution was slowly added dropwise to
400mL of 1% (w/v) Span80 (Merck, Pennsylvania, USA) in
ethyl acetate (AR, Lab Scan, Samutsakorn, Thailand) under
magnetic stirring at 900rpm to prepare the non-crosslinked
microparticles.The emulsification-diffusionprocess took 1h.
The methylene blue, the water-soluble model drug, was
directly dissolved in the gelatin solution before microparticle
preparation. The beaker was tightly covered with aluminum
foil to prevent ethyl acetate from evaporation during the
emulsification-diffusion step. The obtained microparticles
were collected and rinsed with fresh ethyl acetate before
drying in a vacuum oven at room temperature overnight.
For crosslinking, the gelatin solution was crosslinked with
glutaraldehyde for 4h at room temperature under magnetic
stirring before the addition of the water-soluble model drug
and microparticle production.
Starch/gelatin blend microparticles were prepared from
a starch/gelatin blend solution with the same conditions for
the gelatin microparticles as described above. The 1% (w/v)
starch and 1% (w/v) gelatin aqueous solutions were mixed
under magnetic stirring for 30min. The blend microparticles
with starch/gelatin blend ratios of 20/80, 35/65, and 50/50
(w/w) were prepared. The starch/gelatin blend solution was
crosslinked with a glutaraldehyde solution before the blend
microparticle formation. The resulting microparticles were
washed with 0.1M glycine, followed by deionized water to
eliminate the aldehyde residue [14] before being kept in a
desiccator before characterisation of their properties and
drug release testing.
2.3. Characterisation of Drug-Loaded Blend Microparticles.
The morphology of the blend microparticles was analysed
by scanning electron microscopy using a JEOL JSM-6460LV
scanning electron microscope (SEM, Japan). The micropar-
ticle samples were sputter-coated with gold to enhance the
surface conductivity before scanning. The average particle
size of the blend microparticles was determined from sev-
eral SEM images by counting a minimum of 100 particles
using the smile view software (version 1.02). Chemical
functional groups of the blend microparticles were deter-
mined by Fourier transform infrared (FTIR) spectroscopy
using a Perkin-Elmer Spectrum GX FTIR spectropho-
tometer (USA). A resolution of 4cm
−1 and 32 scans was
employed.
Drug loading of the microparticles was measured by dis-
solvingthemicroparticlesin2%(w/v)NaOHsolutionbefore
adjusting to pH 7 with HCl solution. The drug content was
determined using a UV-Vis spectrophotometer (Lambda 25,
USA) at 668nm. According to a predetermined methylene
blue concentration-UV-Vis absorbance standard curve, the
methylenebluemodeldrugconcentrationofthemediumwas
obtained. Theoretical drug loading content (DLCtheoretical)
a n da c t u a ld r u gl o a d i n gc o n t e n t( D L C actual)w e r ec a l c u l a t e d
from (1)a n d( 2) and were used to measure the drug loading
efficiency (DLE) as in (3). Consider the following:
DLCtheoretical (%)
=
feeddrug(mg)
feedstarch/gelatin + feeddrug(mg)
× 100,
(1)
DLCactual (%)
=
encapsulateddrug(mg)
resultingdrug − loadedblendmicroparticles(mg)
× 100,
(2)
DLE(%) =
DLCactual
DLCtheoretical
× 100. (3)
2.4. In Vitro Drug Release Test. An in vitro drug release
test was performed in a phosphate buffer solution (PBS,
0.1M, pH 7.4) at 37
∘C under shaking. The drug-loaded blend
microparticles (∼20mg) were suspended in 2mL of buffer.
Atpredeterminedtimeintervals,1mLofreleasemediumwas
withdrawn after centrifugation at 5,000rpm for 5min. Then
1mL of fresh buffer was added to the original to maintain
t h et o t a lv o l u m e .Th ed r u gr e l e a s ew a sm o n i t o r e db yU V -
Vis spectrophotometry at 𝜆max = 668n ma n dc o m p a r e dt oa
standardcurveofdrugsolution.Cumulativedrugreleasewas
calculated in terms of the ratio of the cumulative mass of the
released drug at a given time against the initial drug loading
in the microparticle sample. In vitro drug release tests were
performed in triplicate (𝑛=3 ).
The data were expressed as mean ± SD. Statistical anal-
ysis was performed using a one-way analysis of variance
(ANOVA).
3. Results and Discussion
3.1. Morphology and Size of Blend Microparticles. The mor-
phology of the gelatin and blend microparticles with and
without crosslinking was determined from SEM images as
shown in Figure 1. All gelatin microparticles had deflated
shapes and smooth surfaces with fine dispersibility (Fig-
ures 1(a)–1(c)) .Th i sm a yb ed u et ot h e mc o n t a i n i n ga n
internal porous structure. However, the gelatin micropar-
ticles crosslinked with 25g glutaraldehyde/100g gelatin, in
Figure 1(c), were nearly spherical in shape.
Figure 1 also shows SEM images of crosslinked blend
microparticles prepared with different starch/gelatin blend
ratios (Figures 1(d)–1(f)) .I tc a nb es e e nt h a tt h e yw e r en e a r l y
spherical in shape and had smooth surfaces. This indicates
thatthestarch/gelatinblendratiodidnotaffectthemorphol-
ogy of the blend microparticles. The crosslinking occurred
between the hydroxyl groups of starch/gelatin molecules andInternational Journal of Biomaterials 3
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Figure 1: SEM images of drug-loaded gelatin microparticles (a) without crosslinking and crosslinked with (b) 12.5g glutaraldehyde/100g
gelatinand(c)25gglutaraldehyde/100ggelatin,anddrug-loadedblendmicroparticleswithstarch/gelatinblendratiosof(d)20/80,(e)35/65,
and (f) 50/50 (w/w) crosslinked with 25g glutaraldehyde/100g starch/gelatin. (All bars = 100𝜇m.)
the aldehyde groups of glutaraldehyde [15, 16], according to
the possible reaction shown in Figure 2.
Internal morphology of the blend microparticles was
observed from broken microparticles, an example of which
is shown in Figure 3 for the 35/65 (w/w) starch/gelatin blend
microparticles. The internal porous structures were detected
throughout the microparticle matrix as shown in Figure 3(a)
a n dm a g n i fi e df u r t h e ri nFigure 3(b).I ti sh y p o t h e s i z e dt h a t
phase separation takes place in the W/O emulsion droplets
during the emulsification-diffusion step before solidification
of the microparticle matrix. A small amount of the ethyl
acetate continuous phase, diffused into the W/O emulsion
droplets, dispersed phase and starch/gelatin matrix, which
was then rapidly solidified to induce the internal porous
structure [17].
The average particle sizes of the blend microparti-
cles measured from the SEM images are summarized in
Table 1.I tw a sf o u n dt h a tt h ea v e r a g es i z eo ft h en o n -
crosslinked gelatin microparticles was 62𝜇m. The aver-
age particle sizes increased slightly as the gelatin was
crosslinked with glutaraldehyde and the glutaraldehyde ratio
was increased. This may be explained by the glutaraldehyde-
crosslinking increasing the viscosity of the gelatin solution.
The higher viscosity of the crosslinked gelatin solution
inducedlargerW/Oemulsiondropletsbeforesolidificationof
the microparticles. The average sizes of the crosslinked blend
microparticles prepared with different starch/gelatin blend
ratios were in the range from 87 to 98𝜇m. The starch/gelatin
blend ratio did not affect the average size of the blend
microparticles.4 International Journal of Biomaterials
Table 1: Average particle size and drug loading of starch/gelatin blend microparticles.
Starch/gelatin
(w/w)
Glutaraldehyde (g)/100g
starch/gelatin
Average particle size
(𝜇m)
DLCactual
(%)
DLE
(%)
0/100 — 62 ± 14 0.57 ± 0.08 29
0/100 12.5 84 ± 16 0.59 ± 0.12 30
0/100 25 92 ± 12 0.58 ± 0.09 30
20/80 25 87 ± 15 0.62 ± 0.14 32
35/65 25 95 ± 18 0.62 ± 0.06 32
50/50 25 98 ± 20 0.58 ± 0.12 30
O O
O O
HO
Starch/gelatin
Starch/gelatin
OH
OH
OH
Glutaraldehyde
Glutaraldehyde-crosslinked starch/gelatin
Figure 2: Possible crosslinking reaction of starch and gelatin by
glutaraldehyde.
3.2. FTIR of Blend Microparticles. FTIR spectra were
used to confirm the chemical functional groups of the
gelatin and starch as shown in Figure 4. For starch powder
(Figure 4(a)), a broad band was observed in the range
from 900 to 1200cm
−1 that is due to polysaccharides
[18, 19]. The FTIR spectrum of the gelatin powder in
Figure 4(b) exhibited absorption bands at 1653cm
−1
(amide I) and 1541cm
−1 (amide II). As would be expected,
band intensities of the polysaccharide characteristics
of the drug-loaded blend microparticles significantly
increased and the amide characteristics decreased as
the starch blend ratio increased as shown in Figures
4(c)–4(f). The FTIR results supported the fact that blend
microparticleswithvariousstarch/gelatinblendratioscanbe
prepared.
3.3. Drug Loading and Drug Release of Blend Microparticles.
The theoretical drug loading content (DLCtheoretical)o ft h e
non-crosslinked and crosslinked microparticles calculated
fromtheweightsofthefeeddrugmodelandstarch/gelatinas
in (1) was 1.96%. The actual drug loading content (DLCactual)
and drug loading efficiency (DLE) of the microparticles
calculated from (2)a n d( 3), respectively, are summarized
in Table 1.Th eD L C actual a n dD L Ew e r ei nt h er a n g e so f
0.57 to 0.62% and 29 to 32%, respectively. The DLE of the
m e t h y l e n eb l u ed r u gm o d e lw a sl o w .Th i sm a yb ed u et o
diffusion out of the small model drug molecules, methylene
blue, during microparticle solidification [11]. However, the
larger model drug molecules, bovine serum albumin, exhib-
ited high DLE value (∼80%) in the polysaccharide-based
microparticles [4]. The results of the drug loading suggested
thattheglutaraldehyde-crosslinkingandstarch/gelatinblend
ratio did not affect the drug loading efficiency of the gelatin
and blend microparticles. These microparticles with similar
DLCactual values were then used to study the influences of
glutaraldehyde ratio and starch/gelatin blend ratio on drug
release behaviours without the effect of drug concentration
gap between the microparticle matrix and the released
medium.
The in vitro drug release of the methylene blue from
the gelatin and blend microparticles was investigated in a
phosphate buffer with pH 7.4 at 37
∘Cf o r2 4h .Figure 5 shows
the drug release profiles of the gelatin microparticles as a
f u n c t i o no ft h eg l u t a r a l d e h y d er a t i o .Th en o n - c r o s s l i n k e d
gelatin microparticles exhibited nearly complete drug release
within 1h (∼95%) due to the fast dissolution of the gelatin
microparticle matrix. The crosslinked gelatin microparticles
showed a decrease in the methylene blue release over the
whole period of time compared to the non-crosslinked
gelatin microparticles as shown in Figure 5.Th ei n i t i a lb u r s t
release within the first hour of release time was followed
by a further sustained release that can be observed for the
crosslinked gelatin microparticles. The mechanism of drug
release consisted of two main steps: swelling-controlled and
erosion-controlled steps [20]. The initial burst release of the
drug model is due to the drug concentration gradient byInternational Journal of Biomaterials 5
(a) (b)
Figure 3: Internal morphology of broken drug-loaded 35/65 (w/w) starch/gelatin blend microparticles crosslinked with 25g
glutaraldehyde/100g starch/gelatin with magnifications of (a) ×1,400 and (b) ×4,000. (Bars = 10 and 5𝜇m for (a) and (b) images, resp.)
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Figure 4: FTIR spectra of (a) starch and (b) gelatin and drug-
loaded blend microparticles with starch/gelatin blend ratios of (c)
0/100,(d)20/80,(e)35/65,and(f)50/50(w/w)crosslinkedwith25g
glutaraldehyde/100g starch/gelatin.
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Figure 5: In vitro drug release profiles of drug-loaded gelatin
microparticles crosslinked with different glutaraldehyde ratios. (⬦)
non-crosslinked gelatin, (◻) 12.5g glutaraldehyde/100g gelatin, and
(Δ) 25g glutaraldehyde/100g gelatin.
matrix swelling. The slow drug release may occur due to
surface erosion or dissolution of the microparticle matrix.
The methylene blue release from the gelatin micropar-
ticles crosslinked with 12.5g and 25g glutaraldehyde/100g
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Figure 6: In vitro drug release profiles of drug-loaded blend
microparticles prepared with starch/gelatin blend ratios of (⬦)
0/100, (Δ)2 0 / 8 0 ,( ◻)3 5 / 6 5 ,a n d( I)5 0 / 5 0( w / w )c r o s s l i n k e dw i t h
25g glutaraldehyde/100g starch/gelatin.
gelatin at 24h release time was about 78% and 74%,
respectively. The glutaraldehyde-crosslinking can decrease
the methylene blue release content. This may be explained
by the crosslinked structure of the gelatin matrix inhibiting
t h ed r u gr e l e a s e .F o ra l lt h ec r o s s l i n k e ds t a r c h / g e l a t i nb l e n d
microparticles, a sustained drug release can be obtained as
shown in Figure 6. For starch/gelatin blend ratios of 0/100,
20/80, 35/65, and 50/50 (w/w), the drug release levels at 24h
were 78%, 85%, 93%, and 97%, respectively. The level of drug
release steadily increased as the starch blend ratio increased.
4. Conclusions
In this research, blending of starch and gelatin results in
formation of nearly spherical microparticles which exhibit a
promise to function as a carrier of water-soluble drug model,
methylene blue. The drug-loaded microparticles prepared in
this paper show sustained release of the drug model. The
SEM images indicate that glutaraldehyde-crosslinking and
starch blending enhance sphericality of the microparticle
shape. The obtained microparticles slightly increase in their
average particle size with increasing glutaraldehyde and
starch blending ratios. The FTIR analysis of microparticles6 International Journal of Biomaterials
confirms the presence of starch and gelatin in the blend
microparticles.
The drug loading efficiency of microparticles is not
influenced by glutaraldehyde-crosslinking and starch blend-
ing. The extent of drug release expressed as percentage of
drug release decreases with increasing glutaraldehyde ratio
and decreasing starch blending ratio. These starch/gelatin
blend microparticles have potential use as controlled release
delivery carriers for water-soluble drugs.
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